Paul R. Walker

No ORCID on file · 1 paper in corpus · active 2023
2023
·doi:10.1101/2023.12.23.573190

The great success of chimeric antigen receptor (CAR)-T cell therapy in B-cell malignancies has prompted its translation to solid tumors. In the case of glioblastoma (GBM), clinical trials have shown modest efficacy, but anti-GBM CAR-T cells…